Navigation Links
Vystar Corporation Engages The Investor Relations Group
Date:2/3/2010

ATLANTA, Feb. 3 /PRNewswire-FirstCall/ -- Vystar® Corporation (OTC Bulletin Board: VYST), the creator of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw material that significantly reduces antigenic proteins found in natural rubber latex, has engaged The Investor Relations Group ("IRG"), a thirteen-year-old, award-winning, corporate communications firm based in New York City, to serve as its investor relations and public relations agency.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100203/CL48049LOGO)

IRG's investor relations team will target specific portfolio managers and equity analysts in the global investment community to increase awareness of Vystar's natural rubber latex product, Vytex NRL. Concurrent with that effort, the public relations team will initiate an outreach campaign targeting editors, writers, and segment producers of local and national trade and consumer online, print, radio, and broadcast media outlets worldwide.

"Vystar has aggressive plans for 2010, and we are confident that IRG will have a great story to tell to the investment community and the media at large," commented Bill Doyle, Chairman and Chief Executive Officer.  "We are proud that Vytex NRL has been approved in its first commercial product, the Envy™ Ultra Thin condom, with labeling allowed by the FDA that indicates a level of antigenic protein of less than two micrograms/dm2.  Additionally, we have several companies evaluating Vytex NRL for use in their products, including various adhesive applications, foam mattresses and pillows, balloons and gloves.  We look forward to working with IRG as we achieve our objectives and will update the investment community as we move ahead."

IRG's corporate communications program includes new media and multimedia initiatives that involve the creation of broadcast-ready corporate videos, podcasts, and the creation of social networking, video service, and micro-blogging accounts. The Investor Relations Group was recently honored with a "Stevie Award" for Investor Relations Program of the Year and named a finalist in the Best Media Website category from the 2009 American Business Awards.

About Vystar Corporation

Based in Duluth, Ga., Vystar Corporation (OTC BB: VYST.OB) is the creator of Vytex® Natural Rubber Latex (NRL), a patented, all-natural raw material that significantly reduces antigenic proteins found in the over 40,000 products made with natural rubber latex and that are believed to cause latex allergies. The first product made with Vytex® NRL, the Envy™ Ultra Thin condom, which is manufactured by Alatech Healthcare LLC of Eufaula, Alabama, was introduced to the US market in 2009. This product gives the consumer first-hand experience with the remarkable benefits of Vytex NRL.  In addition to the condom market, Vystar is working with manufacturers across a broad range of consumer and medical products to bring Vytex NRL to market in adhesives, surgical and exam gloves, and natural rubber latex foam mattresses, pillows and sponges.  For more information, visit www.vytex.com.

About The Investor Relations Group, Inc.

The Investor Relations Group, Inc. (IRG) offers a full-service corporate communications program designed to suit the many unique needs of Alternative Public Offering (APO) companies. The program utilizes a proprietary, targeted approach to reach institutional investors, analysts, and the media-at-large. For further information, please visit the company's website at http://www.investorrelationsgroup.com.

Forward-looking Statements: Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances.  Actual results may differ materially from those included in these statements due to a variety of factors.  More information about these factors is contained in Vystar's filings with the Securities and Exchange Commission.

SOURCE Vystar Corporation

RELATED LINKS
http://www.vytex.com

'/>"/>

SOURCE Vystar Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Techne Corporation Declares Dividend
2. ETEX Corporation Announces Distribution Agreement With OrthoPediatrics Corp.
3. Laerdal Medical and Medical Simulation Corporation Partner to Offer Integrated Training Courses for SimMan(R) Patient Simulators
4. Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities New Ideas for the New Year Conference on Thursday, January 14th
5. LOREAL and Hurel Corporation Announce R&D Collaboration to Develop a Non-Animal Alternative, Microfluidic Biochip
6. Stryker Corporation Announces Pricing of Senior Notes
7. CVS Caremark Corporation Increases Quarterly Dividend 15%
8. Volcano Corporation Announces Preliminary Record Revenues for Fourth Quarter 2009; Total Year Revenues are Expected to Exceed Prior Guidance
9. Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010
10. Colorado-Based Spectranetics Corporation to Pay $5 Million to Resolve Allegations Relating to its Medical Devices
11. Baxa Corporation to Sponsor Free Culture of Safety Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
(Date:9/18/2017)... PROVIDENCE, R.I. , Sept. 18, 2017 ... in the fields of bioinformatics and immune ... to develop a protective avian influenza A (H7N9) vaccine. ... is distantly related to seasonal influenza and ... approaches, which rely on prior exposure to be ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain medications ... from Austin, Texas, has identified a solution. , She developed a prototype for MOTION ... As such, it eliminates the need to turn on a light when taking medication ...
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... ... Ellevate Network, the leading network for professional women, brought together some of ... their inaugural Summit in New York City in June. The event was livestreamed with ... 3 million. To watch the Mobilize Women video, click here . , ...
(Date:10/13/2017)... ... ... Talented host, actor Rob Lowe, is introducing a segment ... of "Success Files," which is an award-winning educational program broadcasted on PBS Member ... with passion and integrity. , Sciatica occurs when the sciatic nerve in the ...
Breaking Medicine News(10 mins):